Skip to main content
AK Medical Holdings Limited logo

AK Medical Holdings Limited — Investor Relations & Filings

Ticker · 1789 HKEX Manufacturing
Filings indexed 292 across all filing types
Latest filing 2025-04-01 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 1789

About AK Medical Holdings Limited

http://www.ak-medical.net

AK Medical Holdings Limited is a specialized medical device company focused on the design, development, production, and marketing of orthopedic implants, including joint, spinal, and trauma products. The company is a global pioneer in applying advanced manufacturing techniques to orthopedic solutions. It was the world's first to commercialize and apply metal additive manufacturing (3D printing/3D ACT) technology for joint replacement and spine care, enabling the precise construction of trabecular-like structures to promote osseointegration and extend implant lifespan. AK Medical also provides comprehensive orthopedic intelligent equipment, such as the Visual Treatment Solution, which integrates 3D surgical planning software and intelligent surgical robots for enhanced precision. Additionally, the company offers full-process personalized customization services (ICOS) to meet individual patient needs and utilizes proprietary Supravit® HA coating applied via Plasma Vacuum Spraying (VPS) for improved implant stability and bone fusion.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change Classification · 1% confidence The document is a statutory Monthly Return under HKEX Listing Rules (Chapter 19B) detailing movements in authorised share capital, issued shares, share options and other capital‐related securities for AK Medical Holdings. It is not an annual, interim, or earnings report, nor a governance or AGM document, and it specifically centres on share issuance and capital changes for the reporting month. This aligns with the “Share Issue/Capital Change” category (Code: SHA).
2025-04-01 English
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount Classification · 1% confidence The document is a cash dividend announcement for AK Medical Holdings Limited, detailing the final dividend per share, ex-dividend date, record date, and payment date. This matches the ‘Notice of Dividend Amount’ category (Code: DIV).
2025-03-26 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
Earnings Release Classification · 1% confidence The document is titled “Announcement of Annual Results for the Year Ended 31 December 2024” and was filed as an exchange announcement (note the HKEX disclaimer at the top). It contains financial highlights, consolidated statements of profit or loss, other comprehensive income, financial position, segment reporting, and accounting policies, along with a final dividend recommendation. This is a preliminary results announcement of the year‐end financials rather than the full Annual Report or a US Form 10‐K. Therefore, it aligns with an Earnings Release (initial periodic financial results announcement). FY 2024
2025-03-26 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 1% confidence The document is a short announcement by AK Medical Holdings Limited regarding the date of its upcoming Board meeting to consider and approve the annual results for the year ended 31 December 2024. It does not contain the actual financial results, any management discussion, dividend details, or changes in board composition. It is not a notice soliciting votes or reporting vote results, nor is it the publication of a report itself. It is a general regulatory announcement required by the stock exchange. Therefore, it fits best under the fallback category of Regulatory Filings (RNS).
2025-03-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 1% confidence The document is a mandatory monthly return (Form FF301) submitted to the Hong Kong Stock Exchange detailing movements in authorised share capital, issued shares, share options, etc. It is not announcing an AGM, dividend, earnings, or M&A activity; it is a routine regulatory submission under the Exchange Listing Rules. Therefore it falls under the catch-all category for miscellaneous regulatory filings (RNS).
2025-03-04 English
ANNOUNCEMENT POSITIVE PROFIT ALERT
Regulatory Filings Classification · 1% confidence The announcement is a Preliminary Profit Alert issued under Listing Rule 13.09 notifying investors of an expected >50% increase in net profit for FY2024 based on unaudited management accounts. It does not present final financial results (so it is not an Earnings Release or Annual Report) nor is it announcing a published report or proxy materials. It is an ad hoc regulatory announcement of inside information and thus best fits the general Regulatory Filings category (RNS).
2025-02-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.